28/09/2024
Establishment of the Technical Working Group (TWG) "Taskforce Thomson" by the Food and Drug Administration (FDA) to Strengthen Regulatory Oversight on Traditional Medicines and Health Supplements
Acknowledging the critical need to enhance and strengthen its administrative and technical capacities in overseeing establishments and products under its jurisdiction, the FDA hereby creates a Technical Working Group (TWG) called the “Taskforce Thomson” to provide policies on the regulation of Traditional Medicines and Health Supplements based on existing laws, rules, and regulations. The TWG shall formulate an Administrative Order (AO) for the registration of Health Supplements under the Center for Food Regulation and Research (CFRR) and an FDA Circular for the registration of Traditional Medicines under the Center for Drug Regulation and Research (CDRR).
Taskforce Thomson derives its name from Samuel Thomson, a self-taught American herbalist and botanist, well-known as the founder of “Thomsonian Medicine.” This alternative system of medicine enjoyed wide popularity in the United States during the 19th century.
By establishing this task force, the FDA aims to give clear guidelines and streamlined registration processes, enhanced regulatory oversight ensuring that only safe, effective and quality products are available and a simplified regulatory framework that encourages innovation and investment, bolstering industry growth and consumer confidence.
Through these concerted efforts, the FDA reaffirms its commitment to protecting public health and promoting the accessibility of safe and effective healthcare products within the country.
